The confrontation between John Lassett and Alvertelli.

Let everyone at Amgen understand it.

This minority shareholder of the company may have some contradiction with the newcomer, Mr. Abel Sephorosa. The cause of the conflict may have been Mr. Abel Sephorosa's father.

All of you there.

Either a shareholder, or a shareholder representative. In the United States, a country of money, it can basically be regarded as an upper class. It's just that Amgen Pharma is not a large enterprise now, so even if it is an upper-class society, it is only an upper-class society near California for the time being.

In a sense.

The rich circles near California know each other. Americans like to have parties so much, and rich people are no exception, and it can even be said that they have more parties.

365 days a year, at least 250 days spent in a party. With so many parties, it's impossible to be attended by the same people every time.

It can be said that among all the people present, even if they have little to do with each other now except on the board of directors of Amgen. But at the intersection of some other parties in California, they must have met each other.

Naturally, some people knew Edward Sephorosa as well as John Lasset.

Some of their grievances.

These people also know some. Now, with John and Alvertelli facing off, the men whispered to their companions about their grievances.

This also made Gordon J. M. Binder didn't know if he should stand up or not.

I am in a difficult situation.

Binder saw Alvertley calmly and said to John, "Mr. Lasseid." I have a suggestion here. Why don't you sell your shares in Amgen to Mr. Sephorosa, who is willing to pay 1.5 times the market price. The current valuation of Amgen's pharmaceutical market is about $350 million to $400 million. Mr. Sephorosa is willing to buy your shares at a valuation of about $500 million. ”

And. ”

Alvertelli faced the others.

"The other gentlemen, too. Mr. Sephorosa asked me to be my representative, and he is willing to buy your shares for $500 million!"

Alvertley's words suddenly stunned the shareholders and shareholder representatives who were still going to watch the show.

A $500 million valuation?

Acquisition of a stake in Amgen Pharmaceuticals?

Stop.

There are really a lot of small shareholders who are excited.

Amgen Pharma has been established for nearly 10 years, and in the past 10 years, it has burned nearly $100 million. If it weren't for the launch of a new drug like EPO the year before last, which allowed the company to renew its life for several years, the company might have collapsed last year.

Although because of the EPO drug, Amgen Pharma is now valued at 300 million or 400 million US dollars, and granulocyte therapy drugs, a new drug that has not yet been marketed, seem to have a very good future.

However, whether the company can solve all the problems of this new drug and then officially launch it. This matter still has some doubts in the minds of many shareholders.

After all, in the pharmaceutical industry, there are too many examples of small pharmaceutical companies like Amgen Pharma investing too much company capital because of the failure of new drug research and development, resulting in the rupture of the capital chain and eventual bankruptcy.

Will Amgen do the same?

In fact, before today's investment in Abel, at least 70% of the company's shareholders had such doubts in their hearts. Even if Lin Fukun and George Lasman repeatedly assured that no matter what, they would definitely be able to develop a new drug.

They still can't dispel that suspicion.

Even John Lassett was a little moved. Coincidentally, recently his company was preparing to take a piece of land by Malibu Beach, and there was some shortfall in funding. Originally, he hoped to get this fund from the bank through a mortgage.

And what he wanted to take out as collateral for the loan was his share in Amgen. John Rashid, one of Amgen's original shareholders, invested $2 million in the $19 million founding fund.

Because of the company's growth and the investment that came later, his shares have been diluted, but now there are close to 3% of the shares. Now, according to the market conditions, his original investment of $2 million has been worth more than $10 million in 10 years.

Abel wants to buy it with 1.5 times the market price, and it will become 15 million US dollars! Just enough to fill the hole he has now, which makes John Lassett very excited.

As the saying goes, money makes the devil grind. Having money can naturally make John Lasseid put down his face and ask Alvertley, "What you just said is true?"

He wants to sell.

$2 million can become $15 million after 10 years. That's more than 7 times at once, and no matter how you look at it, it's a very profitable deal.

John Rashid felt he wasn't wrong.

Not to mention.

He felt that he could sell his shares to the son of someone he didn't like at such a high price than the market price, and he could also cheat the other party.

Why not?!

Alfertley's answer was also simple and straightforward.

"It's true. Abel Sephorosa gave me that authorization. He motioned to the lawyers who had come in the back, and the lawyers quickly stepped forward and handed over some papers.

"These are share transfer contracts. As soon as you sign the contract, the check will be delivered to you immediately. Before today, the money on the cheque will be in your bank account. ”

John Lasset's thick black eyebrows furrowed together like broad beans.

He struggled for a moment.

Eventually, he thought of the difficult loan managers at the three banks he had gone to, and the high interest rates.

"I'll sell!" John Lassett sneered, "I hope Edward Sephorosa, after his son has made such a "wise" investment, will not blow up his son's dog's head!"

Alvertelli shrugged.

An hour and a half later.

Alvertelli received a total of 11 share transfer contracts, and from these shareholders, Abel paid a total of $70 million for a 14% stake.

There are many people who are willing to sell stocks, but most of them are small shareholders, occupying between 1%~3% of the shares. The majority shareholders are some institutions and some wealthy people who are not very bad at money, and they are willing to take risks.

Minority shareholders are not able to withstand pressure.

Basically, these 11 people are all the minority shareholders of the company.

Among them, John Rashid is the one that sells the most.

When I got it from my bank manager, I confirmed that I had added $15 million to my account.

Even John Lassett couldn't help but smile and was even willing to shake Alvertelli's hand and talk.

That is, there is still a little bit of unpleasantness in what he said, and his tone is full of mockery.

"Congratulations. Your boss is such a "smart guy"!hahaha, it's definitely a good deal. For us, of course!"

As he spoke, he pointed to himself and the other 10 small shareholders who had sold their shares, laughing.

This made the 10 small shareholders laugh too, and for a while the air was full of happy factors.

And then......

Peng!

The door to the company's boardroom was suddenly slammed open, and everyone saw that the chairman of the company, Mr. George Lassman, rushed in with excitement like a madman.

"Good news, everyone!"